Scene Health's $17.7 million Series B funding round was led by ABS Capital Partners and includes participation from Claritas Health Ventures, PTX Capital, Kapor Capital and Healthworx, the investment arm of CareFirst BlueCross BlueShield. Since Scene Health was founded in 2014, it has raised more than $25 million total.
The company, which uses asynchronous video visits to help patients take their medication, raised a series A round led by Claritas Health Ventures.
In the medical device track of the online pitch contest, five companies will present their technologies, which span medical imaging to clearing clogs from feeding tubes. Register now!
Johns Hopkins Medicine is using digital health startup Emocha’s telehealth tool to monitor healthcare providers for Covid-19 symptoms. The health system had previously used Emocha’s software for other infectious diseases.
During the three-month program, UMHP members with type 2 diabetes will use emocha's app to submit daily videos of themselves taking their medication.
With an eye to the successful use cases in Texas and Puerto Rico, emocha CEO Sebastian Seiguer hopes to convert more public health departments into customers in 2018.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The partnership will support the development of a mobile application to give users easy access to a diagnostic device to initiate diagnostic tests and view results on their mobile devices.
Emocha Managing Director Morad Elmi said he expects the company to add at least three more states by the end of the year.
emocha Mobile Health has won the support of the South Africa department of health to adopt its technology to improve treatment for patients with multi-drug resistant tuberculosis across the country, according to a company statement.
Emocha, a health IT startup that developed an interesting approach to tackling the challenge of medication adherence by recording video selfies, has inked a deal with Harris County’s public health department to use its technology for TB patients there. The Baltimore-based company’s remote patient management platform miDOT platform will be applied to patients who live […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Baltimore-based emocha Mobile Health is partnering with the city of Baltimore’s Health Department on a pilot program to improve medication adherence, particularly among tuberculosis patients and the monitoring that comes with it. Health Data Management reports that the health department will use emocha’s medication adherence app, miDOT, to hep TB patients stay on track with […]
What started as a Johns Hopkins Hospital program to train healthcare workers to treat HIV in Uganda has evolved into a multimedia platform for adherence, clinical trials and chronic diseases rolled into a healthcare startup, Emocha. In a presentation at DreamIt Health Baltimore’s demo day, CEO Sebastian Seiguer talked about the company’s origins at Johns […]
